Jiawei Liu
1
Junling Wang
1*
Zhitong Bing
2*The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Genet.
Sec. Cancer Genetics and Oncogenomics
Volume 15 - 2024 |
doi: 10.3389/fgene.2024.1404348
This article is part of the Research Topic Immunotherapy and Biomarkers for Lung Cancer View all 4 articles
Comprehensive pan-cancer analysis and experiments revealed R3HDM1 as a novel predictive biomarker for prognosis and immune therapy response
Provisionally accepted- 1 Lanzhou University, Lanzhou, China
- 2 Institute of Modern Physics, Chinese Academy of Sciences (CAS), Lanzhou, Gansu Province, China
R3HDM1, a member of the protein family similar to the potential key cancer gene ARPP21 (R3HDM3), has received limited attention in cancer-related research. Leveraging various bioinformatics tools, we uncovered distinct expressions of R3HDM1 across different cancers, indicating its potential as an early diagnostic biomarker, validated within cell lines. Additionally, cell phenotypic experiments were conducted to preliminarily confirm the pivotal role of R3HDM1 in proliferation and migration processes in lung adenocarcinoma cell lines. Furthermore, our study revealed associations of R3HDM1 expression with clinical characteristics of cancer, metabolic pathways, and immune-related pathways. Exploring the relationship between R3HDM1 expression in pan-cancer and infiltration of immune cell subtypes provides valuable insights into the role of R3HDM1 in the tumor immune microenvironment. Overall, this research aims to establish R3HDM1 as a promising molecular marker for predicting cancer patient outcomes and assessing the effectiveness of immune therapy interventions, thereby aiding in the development of more efficient cancer treatments and potential novel anti-tumor therapies, particularly for lung adenocarcinoma patients.
Keywords: R3HDM1, diagnosis, Pan-cancer, prognosis, TME, LUAD
Received: 20 Mar 2024; Accepted: 10 Sep 2024.
Copyright: © 2024 Liu, Wang and Bing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Junling Wang, Lanzhou University, Lanzhou, China
Zhitong Bing, Institute of Modern Physics, Chinese Academy of Sciences (CAS), Lanzhou, 730000, Gansu Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.